The Illusion of Quality at the USPTO

Is there any consequence to improper rejections, being reversed, re-opening prosecution, or generally being unreasonble and difficult? Surely the USPTO’s quality review program would be evaluating such actions.

The USPTO has put substantial efforts in addressing quality. Even the AIA legislation cited patent quality as one of its main drivers. During examination (the bulk of what the USPTO does), MPEP 1308.03 (Quality Review Program for Examined Patent Applications) describes the program (emphasis added):

The Office of Patent Quality Assurance administers a program for reviewing the quality of the examination of patent applications. The general purpose of the program is to improve patent quality and increase the likelihood of patents being found to be valid.

The quality review is conducted by Review Quality Assurance Specialists on a randomly selected sample of allowed applications from each examiner. The sample is computer generated under the office-wide computer system (PALM), which selects a predetermined number of allowed applications from each examiner per year for review. A subsample of the selected allowed applications are both reviewed and independently searched by the reviewers. The only applications excluded from the sample are those in which there has been a decision by the Board of Patent Appeals and Interferences, or by a court.

It should be stressed that the only reviewed applications, admittedly, are ones that are allowed. While this is at least theoretically relevant in identifying improper allowances, it does nothing to address improper rejections or other improper rejections that cause an applicant to abandon their application. The USPTO’s quality review program thus has no impact on the following elements (which seem highly relevant to patent examination quality:

  • improper restrictions

  • improper petition decisions

  • improper substantive rejections

  • improper procedural rejections

  • improper re-opening after an appeal brief

  • improper re-opening after a reversal

  • improper final rejections

  • improper objections

  • refusal to conduct a video-based interview

  • and so on…

One can see that to have a perfect quality record, all that is needed is to simply reject no matter what. Some readers have suggested that an examiner feels some pressure going to an appeal conference with a bad rejection. This anecdotal explanation has some draw, and there is the negative consequence of having to form a new rejection with no points if prosecution is re-opened. However, beyond this minor inconvenience, it is unclear of any real consequence. Further, if the supervisor or primary is supportive of maintaining bad rejections, an appeal conference will do nothing (as the examiner and supervisor/primary can always out-vote the third member).

Another internal quality review program by the USPTO is described as follows:

As part of the USPTO’s quality assurance efforts, each Technology Center (TC) has supervisors and TC reviewers who conduct numerous quality reviews of work products each year for evaluations of employee quality as well as to provide coaching and mentoring based on their findings. In addition to these TC reviews, the Office of Patent Quality Assurance (OPQA) audits a random sample of work products each fiscal year. The results from the OPQA random reviews are used to generate the USPTO’s statutory compliance measures

Looking to these random quality reviews, here is some data published by the USPTO for 2021. According to their own internal reviews, approximately 25% of actions have an improper (under at least one of 101, 102, 103, and 112) rejection.

According to the USPTO, they conduct approximately 12,000 such random reviews per year. The data is used to provide “meaningful feedback to TC management and quality assurance specialists and facilitates the identification of quality trends, training opportunities, as well as an evaluation of recent training at the corps level and below.”

The different review of allowed applications (where an improper allowance results in specific action (e.g., re-opening) of an application) stands in start contrast to the nebulous status of the randomly selected applications that are admittedly improperly rejected (where it seems the USPTO is happy to let them remain improperly rejected and to not even inform the applicant of this fact).

So perhaps if an examiner intent on rejecting and wearing an applicant down has one of their improper rejections randomly selected, they might possibly receive some coaching. Otherwise, it appears that they can restrict all they want (until an applicant successfully petitions, and even then the result is to do the work they should have done the first time), and they can improperly reject all they want where an applicant can be forced to enter an endless loop of appeal re-openings.

The situation reminds me of a (CORRECTION – early 90s) metal song by Ratt – Heads I Win, Tails You Lose.

<div class="sqs-video-wrapper" data-provider-name="YouTube" data-html="

“>

Until there is true symmetric quality review on both sides (rejections and allowances), the idea of patent quality at the USPTO is an illusion.


Comments

One response to “The Illusion of Quality at the USPTO”

  1. Julie Burke Avatar
    Julie Burke

    As a former USPTO Quality Assurance Specialist, I agree with your analysis, findings and assessments. In particular, "[o]ne can see that to have a perfect quality record, all that is needed is to simply reject no matter what."

    Back in ~2010, then-POPA President Robert Budens explained to me that quality major activity 19 of the revised performance and appraisal plan (PAP) was carefully crafted by bunkered USPTO management and POPA reps agreement to give patent examiners (and management) coverage when a final office action included improper rejections. As long as each claim was covered by one correct rejection, no quality impact exists for the inclusion of additional improper rejections in a final office action.

    Properly rejecting all rejectable claims in a final rejection; properly allowing all claims in an allowance."

    Parse those words.

    The PAP’s quality element does not require each rejection of each claim to be proper in a final Office action.

    Colloquially, I heard this described as throwing a bunch of spaghetti on the wall with the hopes that one noodle for each claim would stick.

    Additionally, even though a final office action should identify allowable subject matter when appropriate, this activity is not part the current PAP’s REQUIRED quality elements.

    Instead, USPTO and POPA have conflated indication of allowable subject matter with compact prosecution. In the FY2021 PAP, evaluation of Legal task QMA 14 "promoting compact prosecution…" was downgraded to a "non-error based assessment."

    Note the FY2021 PAP’s quality element lists nineteen major quality activities. Seven these activities were downgraded to evaluation under the USPTO’s new homegrown "non-error based assessment."

    Promoting compact prosecution and properly identifying allowable subject matter in a final office action are tasks that examiners are no longer required to do correctly.

    The USPTO’s FY2021 PAP (portrayed to Congress as a Roadmap to Improved Patent Quality) relegated "indication of allowable subject, as appropriate" to one of nine OPTIONAL activities under Indicia 3, Compact Prosecution.

    An examiner who performs one of the nine optional compact prosecution activities in the majority of their applications may be eligible for a higher rating. Examiners who perform none of the nine optional activities can still be rated a Fully Successfully, i.e., sound good performance.

    https://ipwatchdog.com/2021/07/01/usptos-roadmap-improved-patent-quality-lead-lake-wobegon/id=135152/

    Like

Leave a comment